Skip to content
The Policy VaultThe Policy Vault

Cabometyx (cabozantinib tablets) — Cigna

Endometrial Carcinoma

Initial criteria

  • Patient age ≥ 18 years
  • Patient has tried one systemic regimen

Approval duration

1 year